Corcept Therapeutics Inc. Hits New 52-Week High at $3.98 (CORT)
Shares of Corcept Therapeutics (NASDAQ:CORT) hit a new 52-week high during mid-day trading on Friday, AnalystRatings.Net reports. The stock traded as high as $3.98 and last traded at $3.38, with a volume of 897,168 shares trading hands. The stock had previously closed at $3.73.
Separately, analysts at Stifel Nicolaus downgraded shares of Corcept Therapeutics from a “buy” rating to a “hold” rating in a research note to investors on Monday, January 13th. Five analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and an average target price of $2.33.
Corcept Therapeutics has a 52-week low of $1.47 and a 52-week high of $3.83. The stock has a 50-day moving average of $3.10 and a 200-day moving average of $2.10. The company’s market cap is $343.4 million.
Corcept Therapeutics (NASDAQ:CORT) last issued its quarterly earnings data on Thursday, January 30th. The company reported ($0.10) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.12) by $0.02. Analysts expect that Corcept Therapeutics will post $-0.46 EPS for the current fiscal year.
Corcept Therapeutics Inc is a United States-based pharmaceutical company. The Company is involved in the discovery and development of drugs that regulate the effects of cortisol or also known as the stress hormone.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.